Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Avoid Ten Lifestyle Group (TENG) by Steve Moore in ShareProphets
- Avoid Biome Technologies (BIOM) by Steve Moore in ShareProphets
- Buy Aviva (AV.) by Harvey Jones in The Motley Fool
- Buy CMC Markets (CMCX) by Harvey Jones in The Motley Fool
- Buy ITV (ITV) by Simon Watkins in The Motley Fool
- Buy Legal & General Group (LGEN) by Simon Watkins in The Motley Fool
- Hold Vodafone Group (VOD) by DZ Bank
- Buy Premier Foods (PFD) by Jefferies
- Buy Intermediate Capital Group (ICG) by Deutsche Bank
- Overweight WH Smith (SMWH) by JP Morgan
- Outperform TT Electronics (TTG) by RBC Capital
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Goldman Sachs
- Neutral Dr. Martens (DOCS) by Goldman Sachs
- Buy Intermediate Capital Group (ICG) by Goldman Sachs
- Neutral Vistry Group (VTY) by JP Morgan
- Buy Babcock International Group (BAB) by Jefferies
- Buy Convatec Group (CTEC) by Jefferies
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Marks Electrical Group (MRK) by Steve Moore in ShareProphets
Maxcyte (DI) (MXCT) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Maxcyte (DI) (MXCT)
| Latest Bid : 270.00p | Latest Ask : 280.00p |
| High Today : 278.00p | Low Today : 270.00p |
| This Years High : 420.00p | This Years Low : 262.00p |
| Volume : 7,609 | MKT Cap : £288.75M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Maxcyte (DI) (MXCT) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.Maxcyte (DI) (MXCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | 12.24% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -23.61% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -34.52% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -61.96% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -70.00% |
Maxcyte (DI) (MXCT) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 270.00p | Latest Ask : 280.00p |
| High Today : 278.00p | Low Today : 270.00p |
| This Years High : 420.00p | This Years Low : 262.00p |
| Volume : 7,609 | MKT Cap : £288.75M |
Maxcyte (DI) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Maxcyte (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | 12.24% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -23.61% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -34.52% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -61.96% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -70.00% |